These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 11010828

  • 1. An analysis of some hypotheses related to the Chingelput bacille Calmette-Guérin trial.
    Smith D, Wiegeshaus E, Balasubramanian V.
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S77-80. PubMed ID: 11010828
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK, Vesosky B, Beamer GL, Stromberg P, Turner J.
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z, de Waard JH, de Larrea CF, Borges R, Convit J.
    Vaccine; 2008 Oct 16; 26(44):5575-81. PubMed ID: 18723065
    [Abstract] [Full Text] [Related]

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 16; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 10. Influence of BCG vaccine strain on the immune response and protection against tuberculosis.
    Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N.
    FEMS Microbiol Rev; 2008 Aug 16; 32(5):821-41. PubMed ID: 18616602
    [Abstract] [Full Text] [Related]

  • 11. Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine.
    Comstock GW.
    Clin Infect Dis; 2000 Jun 16; 30 Suppl 3():S250-3. PubMed ID: 10875793
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
    Brantsaeter AB, Romanus V, Andersen PH, Heldal E.
    Int J Tuberc Lung Dis; 2009 Apr 16; 13(4):440-5. PubMed ID: 19335948
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N.
    Vaccine; 2007 Jan 02; 25(1):14-8. PubMed ID: 16959383
    [Abstract] [Full Text] [Related]

  • 17. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP.
    Indian J Public Health; 2004 Jan 02; 48(2):70-7. PubMed ID: 15709589
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.